M. Stepanova
Institute of Oncology NN Petrov · 23 works · 27 citations · h-index 3
Top works
- Case Report: Multiple Causes of Cardiac Death After the First Infusion of Atezolizumab: Histopathological and Immunohistochemical Findings
- Real world efficacy of immunotherapy in nonsmall cell lung cancer
- Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome
- EVOLUTION OF DRUG THERAPY FOR LUNG CANCER WITH EGFR INHIBITORS: NEW ASPECTS
- Investigation of the mechanisms of resistance to osimertinib in patients with T790M-associated NSCLC
- Personalized therapy in solid tumors: results of a retrospective multicentre study of the clinical applicability of the FoundationOne® Medicine Test
- Применение панелей комплексного молекулярного профилирования при опухолях желудочно-кишечного тракта. Обзор литературы и собственные результаты
- Clinical application of next-generation sequencing in cancer patients.
- P2.14-30 Predictive Value of ctDNA in Patients with EGFR Positive NSCLC Receiving 3rd Generation TKI
- Surgical Removal of Residual Tumor Masses in Patients Undergoing Targeted Therapy for EGFR ‐Mutated Locally Advanced or Metastatic Lung Cancer
- Comparison of the treatment results in patients with inoperable non-small cell lung cancer in clinical trials and in standard clinical practice using the pseudorandomization method
- 730 PROTEOMICS BIOMARKERS PREDICTING HISTOLOGIC NON-ALCOHOLIC STEATOHEAPTITIS AND FIBROSIS
- Macrophage-based models for diagnostics and therapy development
- Utility of public Knowledge Bases (KB) for comprehensive tumor molecular profiling (CTMP) result interpretation.
- 1197P Changes in the concentration of EGFR-mutated (EGFR-M+) plasma DNA in the first hours of TKI therapy allow the prediction of tumour response in patients with EGFR-M+ NSCLC
- Dynamics of ctDNA in patients with NSCLC
- ОТЕЧЕСТВЕННЫЙ МНОГОЦЕНТРОВОЙ ОПЫТ ПРИМЕНЕНИЯ ТАЛАЗОПАРИБА В ЛЕЧЕНИИ БОЛЬНЫХ BRCA-АССОЦИИРОВАННЫМ МЕТАСТАТИЧЕСКИМ РАКОМ МОЛОЧНОЙ ЖЕЛЕЗЫ
- Prognostic significance of longitudinal evaluation on egfr mutant ctdna during tki treatment in nsclc
- Monocyte activation: Cellular test for development of diagnostics and therapy
- Prediction of PFS using a dynamic assessment of ctDNA in patients with EGFR mutated NSCLC with osimertinib therapy